Advertisement
Advertisement

PTN

PTN logo

Palatin Technologies, Inc.

0.766
USD
-0.01
-1.88%
Mar 11, 15:59 UTC -4
Closed
exchange

After-Market

0.762

0
-0.52%

Palatin Technologies, Inc. Profile

About

Palatin Technologies, Inc is a development-stage medical technology companyinvolved in developing and commercializing products and technologies fordiagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies.

Info & Links

CEO

Carl Spana

Headquarters

4B CEDAR BROOK DRIVE
CRANBURY, NJ 08512, UNITED STATES

Sector

Medical

Auditor

KPMG LLP

Share holders

90

Employees

30

Palatin Technologies, Inc. Statistics

Valuation Measures

Market Capitalization2

19.82M

Enterprise Value

16.40M

Enterprise Value/EBITDA(ttm)

-0.59

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.74

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-589.32%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

7005.50%

Return on Assets(ttm)

-365.57%

Income Statement

Revenue(ttm)

350.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

350.00K

EBITDA(ttm)3

-27.62M

Net Income Available to Common(ttm)

-26.95M

Diluted EPS(ttm)

-1.55

Share Statistics

Beta (5Y Monthly)

0.87

52-Week Change

-58.37%

S&P 500 52-Week Change

7.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

26.01M

Dividend Yield

0.00%

Float4

18.16M

% Held by Insiders

7.10%

% Held by Institutions

11.50%

Balance Sheet

Total Cash(mrq)

3.42M

Total Cash Per Share(mrq)

0.13

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.38%

Quick Ratio(mrq)

0.38%

Book Value Per Share(mrq)

-0.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.57

Free Cash Flow(ytd)

-11.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement